Characteristics of clinical trials to support approval of orphan drugs for neurological disorders by the Japanese regulatory agency

被引:0
|
作者
Nakamura, H. [1 ]
Takeda, S. [2 ]
Iwasaki, M. [3 ]
机构
[1] Natl Ctr Neurol & Psychiat, Translat Med Ctr, Kodaira, Tokyo, Japan
[2] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Kodaira, Tokyo, Japan
[3] Univ Yamanashi, Dept Clin Res, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi, Japan
关键词
D O I
10.1016/j.jns.2017.08.2385
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
2354
引用
收藏
页码:847 / 847
页数:1
相关论文
共 50 条
  • [41] The clinical use of curcumin on neurological disorders: An updated systematic review of clinical trials
    Mohseni, Maryam
    Sahebkar, Amirhossein
    Askari, Gholamreza
    Johnston, Thomas P.
    Alikiaii, Babak
    Bagherniya, Mohammad
    PHYTOTHERAPY RESEARCH, 2021, 35 (12) : 6862 - 6882
  • [42] Clinical Characteristics and Prognosis of Neurological Disorders During Pregnancy
    Wang, Jia-Yao
    Wang, Zhi-Mei
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2025, 17 : 475 - 484
  • [43] Clinical characteristics and management of unipolar depressive disorders comorbid with neurological disorders
    Judd, LL
    Kunovac, JL
    NEUROPSYCHOBIOLOGY, 1998, 37 (02) : 84 - 87
  • [44] Regulatory and clinical development to support the approval of advanced therapies medicinal products in Japan
    Carolina, Iglesias-Lopez
    Antonia, Agusti
    Merce, Obach
    Antonio, Vallano
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (07) : 831 - 842
  • [45] Characteristics of Clinical Trials for the US Food and Drug Administration Accelerated Approval and Subsequent Confirmatory Trials: Implications for Drug Approval in Japan
    Mamiya, Hiroaki
    Narukawa, Mamoru
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2024, 47 (07) : 1345 - 1349
  • [46] Clinical pharmacology information in regulatory submissions and labeling: A comparative analysis of orphan and non-orphan drugs approved by the FDA
    Hsieh, Julie
    Sahre, Martina
    Yang, Xinning
    Madabushi, Rajanikanth
    Ramamoorthy, Anuradha
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (11): : 2583 - 2596
  • [47] Extended Model-Informed Drug Development: Beyond Clinical Trials and Regulatory Approval
    Kamal, Mohamed A.
    Ganguly, Samit
    Kadambi, Ananth
    Smith, Patrick F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (03) : 518 - 521
  • [48] Moving Towards Preconditioning for Neurological Disorders: Are We Ready for Clinical Trials?
    Sebastian Koch
    Translational Stroke Research, 2013, 4 : 15 - 18
  • [49] Moving Towards Preconditioning for Neurological Disorders: Are We Ready for Clinical Trials?
    Koch, Sebastian
    TRANSLATIONAL STROKE RESEARCH, 2013, 4 (01) : 15 - 18
  • [50] Clinical trials of intranasal delivery for treating neurological disorders - a critical review
    Liu, Xinfeng
    EXPERT OPINION ON DRUG DELIVERY, 2011, 8 (12) : 1681 - 1690